Alliance for impact – advancing CGT development in Europe
By Lindsay Davies
Gilead partners to advance novel oral oncology drug
By Catherine Eckford (European Pharmaceutical Review)
iPSC-CAR-NK cell therapy exhibits autoimmune potential
By Catherine Eckford (European Pharmaceutical Review)
Life sciences a “priority sector” in UK Industrial Strategy
By Catherine Eckford (European Pharmaceutical Review)